{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T17:06:50Z","timestamp":1790528810724,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:00:00Z","timestamp":1517961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:00:00Z","timestamp":1517961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In a previous study the small molecule SJP-L-5 that inhibits HIV replication, has been shown to block uncoating of the viral capsid. Continued study showed that SJP-L-5 might hinder HIV capsid uncoating by blocking the completion of reverse transcription. However, to date, the mechanism has not been fully elucidated. Here, the effects of SJP-L-5 for reverse transcription were explored via quantitative PCR, DIG-labelled ELISA, fluorescent resonance energy transfer, and Southern blot assays. We also analyzed the resistance profile of this compound against reverse transcriptase. Our results show that SJP-L-5 preferentially inhibits PPT primed plus-strand DNA synthesis (EC<jats:sub>50<\/jats:sub>\u2009=\u200913.4\u2009\u00b1\u20093.0\u2009\u03bcM) over RNA primed minus-strand DNA synthesis (EC<jats:sub>50<\/jats:sub>\u2009&gt;\u20093,646\u2009\u03bcM), resulting in formation of five segmented plus-strand DNA and loss of HIV DNA flap, suggesting failure of both nuclear import and integration. Moreover, resistance study evidenced that SJP-L-5 requires the amino acid residues Val108 and Tyr181 to exert an inhibitory effect. These results indicate\u00a0SJP-L-5 as a new non-nucleoside reverse transcriptase inhibitor that inhibits HIV-1 polypurine tract primed plus-strand DNA synthesis, initiating HIV-1 down-stream plus-strand DNA synthesis at multiple sites under drug pressure.<\/jats:p>","DOI":"10.1038\/s41598-018-20954-5","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T15:15:35Z","timestamp":1517498135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["SJP-L-5 inhibits HIV-1 polypurine tract primed plus-strand DNA elongation, indicating viral DNA synthesis initiation at multiple sites under drug pressure"],"prefix":"10.1038","volume":"8","author":[{"given":"Xing-Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-Meng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Tang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,7]]},"reference":[{"key":"20954_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.coviro.2013.03.012","volume":"3","author":"K Das","year":"2013","unstructured":"Das, K. & Arnold, E. HIV-1 reverse transcriptase and antiviral drug resistance. Part 1. Curr. Opin. Virol. 3, 111\u2013118 (2013).","journal-title":"Curr. Opin. Virol."},{"key":"20954_CR2","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1099\/0022-1317-77-9-1987","volume":"77","author":"J-J Kupiec","year":"1996","unstructured":"Kupiec, J.-J. & Sonigo, P. Reverse Transcriptase Jumps and Gaps. J. Gen. Virol. 77, 1987\u20131991 (1996).","journal-title":"J. Gen. Virol."},{"key":"20954_CR3","doi-asserted-by":"publisher","first-page":"40850","DOI":"10.1074\/jbc.R112.389056","volume":"287","author":"SFJ Le Grice","year":"2012","unstructured":"Le Grice, S. F. J. Human Immunodeficiency Virus Reverse Transcriptase: 25 Years of Research, Drug Discovery, and Promise. J. Biol. Chem. 287, 40850\u201340857 (2012).","journal-title":"J. Biol. Chem."},{"key":"20954_CR4","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1128\/jvi.66.5.2814-2820.1992","volume":"66","author":"P Charneau","year":"1992","unstructured":"Charneau, P., Alizon, M. & Clavel, F. A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J. Virol. 66, 2814\u20132820 (1992).","journal-title":"J. Virol."},{"key":"20954_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0092-8674(00)80828-4","volume":"101","author":"V Zennou","year":"2000","unstructured":"Zennou, V. et al. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101, 173\u2013185 (2000).","journal-title":"Cell"},{"key":"20954_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.antiviral.2009.09.008","volume":"85","author":"MP de Bethune","year":"2010","unstructured":"de Bethune, M. P. Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989-2009). Antivir. Res. 85, 75\u201390 (2010).","journal-title":"Antivir. Res."},{"key":"20954_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12866-015-0605-3","volume":"15","author":"R Bai","year":"2015","unstructured":"Bai, R. et al. SJP-L-5, a novel small-molecule compound, inhibits HIV-1 infection by blocking viral DNA nuclear entry. BMC Microbol. 15, 274 (2015).","journal-title":"BMC Microbol."},{"key":"20954_CR8","doi-asserted-by":"publisher","first-page":"9975","DOI":"10.1073\/pnas.1014522108","volume":"108","author":"AE Hulme","year":"2011","unstructured":"Hulme, A. E., Perez, O. & Hope, T. J. Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription. Proc. Natl. Acad. Sci. USA 108, 9975\u20139980 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"20954_CR9","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1128\/jvi.65.5.2415-2421.1991","volume":"65","author":"P Charneau","year":"1991","unstructured":"Charneau, P. & Clavel, F. A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J. Virol. 65, 2415\u20132421 (1991).","journal-title":"J. Virol."},{"key":"20954_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF01319237","volume":"116","author":"O Hungnes","year":"1991","unstructured":"Hungnes, O., Tjotta, E. & Grinde, B. The Plus Strand Is Discontinuous in a Subpopulation of Unintegrated HIV-1 DNA. Arch. Virol. 116, 133\u2013141 (1991).","journal-title":"Arch. Virol."},{"key":"20954_CR11","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1126\/science.1701568","volume":"250","author":"VJ Merluzzi","year":"1990","unstructured":"Merluzzi, V. J. et al. Inhibition of HIV-1 Replication by a Nonnucleoside Reverse-Transcriptase Inhibitor. Science 250, 1411\u20131413 (1990).","journal-title":"Science"},{"key":"20954_CR12","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1128\/AAC.37.5.1127","volume":"37","author":"TJ Dueweke","year":"1993","unstructured":"Dueweke, T. J. et al. U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication. Antimicrob. Agents Chemother. 37, 1127\u20131131 (1993).","journal-title":"Antimicrob. Agents Chemother."},{"key":"20954_CR13","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1128\/AAC.39.12.2602","volume":"39","author":"SD Young","year":"1995","unstructured":"Young, S. D. et al. L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. 39, 2602\u20132605 (1995).","journal-title":"Antimicrob. Agents Chemother."},{"key":"20954_CR14","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1128\/AAC.48.12.4680-4686.2004","volume":"48","author":"K Andries","year":"2004","unstructured":"Andries, K. et al. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 48, 4680\u20134686 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"20954_CR15","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1128\/AAC.00986-09","volume":"54","author":"H Azijn","year":"2010","unstructured":"Azijn, H. et al. TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1. Antimicrob. Agents Chemother. 54, 718\u2013727 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"20954_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0092-8674(79)90357-X","volume":"18","author":"E Gilboa","year":"1979","unstructured":"Gilboa, E., Mitra, S. W., Goff, S. & Baltimore, D. Detailed Model of Reverse Transcription and Tests of Crucial Aspects. Cell 18, 93\u2013100 (1979).","journal-title":"Cell"},{"key":"20954_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1177\/1087057111402201","volume":"16","author":"E Cauchon","year":"2011","unstructured":"Cauchon, E., Falgueyret, J. P., Auger, A. & Melnyk, R. A. A High-Throughput Continuous Assay for Screening and Characterization of Inhibitors of HIV Reverse-Transcriptase DNA Polymerase Activity. J. Biomol. Screen. 16, 518\u2013524 (2011).","journal-title":"J. Biomol. Screen."},{"key":"20954_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.antiviral.2013.01.007","volume":"98","author":"L Menendez-Arias","year":"2013","unstructured":"Menendez-Arias, L. Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments. Antivir. Res. 98, 93\u2013120 (2013).","journal-title":"Antivir. Res."},{"key":"20954_CR19","doi-asserted-by":"publisher","first-page":"a007161","DOI":"10.1101\/cshperspect.a007161","volume":"2","author":"EJ Arts","year":"2012","unstructured":"Arts, E. J. & Hazuda, D. J. HIV-1 Antiretroviral Drug Therapy. Cold Spring Harb. Perspect. Med. 2, a007161\u2013a007161 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"20954_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1128\/AAC.01209-10","volume":"55","author":"M Kobayashi","year":"2011","unstructured":"Kobayashi, M. et al. In Vitro Antiretroviral Properties of S\/GSK1349572, a Next-Generation HIV Integrase Inhibitor. Antimicrob. Agents Chemother. 55, 813\u2013821 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"20954_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ejmech.2014.06.061","volume":"83","author":"EJ Velthuisen","year":"2014","unstructured":"Velthuisen, E. J. et al. Pyridopyrimidinone inhibitors of HIV-1 RNase H. Euro. J. Med. Chem. 83, 609\u2013616 (2014).","journal-title":"Euro. J. Med. Chem."},{"key":"20954_CR22","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1128\/AAC.01594-10","volume":"55","author":"EB Lansdon","year":"2011","unstructured":"Lansdon, E. B. et al. Structural and Binding Analysis of Pyrimidinol Carboxylic Acid and N-Hydroxy Quinazolinedione HIV-1 RNase H Inhibitors. Antimicrob. Agents Chemother. 55, 2905\u20132915 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"20954_CR23","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1038\/sj.emboj.7601740","volume":"26","author":"NJ Arhel","year":"2007","unstructured":"Arhel, N. J. et al. HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore. EMBO J. 26, 3025\u20133037 (2007).","journal-title":"EMBO J."},{"key":"20954_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.virusres.2016.12.019","volume":"234","author":"L Menendez-Arias","year":"2017","unstructured":"Menendez-Arias, L., Sebastian-Martin, A. & Alvarez, M. Viral reverse transcriptases. Virus Res. 234, 153\u2013176 (2017).","journal-title":"Virus Res."},{"key":"20954_CR25","doi-asserted-by":"publisher","first-page":"12773","DOI":"10.1128\/JVI.79.20.12773-12782.2005","volume":"79","author":"J Vingerhoets","year":"2005","unstructured":"Vingerhoets, J. et al. TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments. J. Virol. 79, 12773\u201312782 (2005).","journal-title":"J. Virol."},{"key":"20954_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.meegid.2016.08.031","volume":"46","author":"DS Clutter","year":"2016","unstructured":"Clutter, D. S., Jordan, M. R., Bertagnolio, S. & Shafer, R. W. HIV-1 drug resistance and resistance testing. Infect., Genet. Evol. 46, 292\u2013307 (2016).","journal-title":"Infect., Genet. Evol."},{"key":"20954_CR27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/jvi.43.2.544-554.1982","volume":"43","author":"RP Junghans","year":"1982","unstructured":"Junghans, R. P., Boone, L. R. & Skalka, A. M. Products of reverse transcription in avian retrovirus analyzed by electron microscopy. J. Virol. 43, 544\u2013554 (1982).","journal-title":"J. Virol."},{"key":"20954_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.pep.2003.10.018","volume":"34","author":"EW Hou","year":"2004","unstructured":"Hou, E. W., Prasad, R., Beard, W. A. & Wilson, S. H. High-level expression and purification of untagged and histidine-tagged HIV-1 reverse transcriptase. Protein Expr. Purif. 34, 75\u201386 (2004).","journal-title":"Protein Expr. Purif."},{"key":"20954_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ab.2003.06.001","volume":"322","author":"MA Parniak","year":"2003","unstructured":"Parniak, M. A., Min, K. L., Budihas, S. R., Le Grice, S. F. J. & Beutler, J. A. A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity. Anal. Biochem. 322, 33\u201339 (2003).","journal-title":"Anal. Biochem."},{"key":"20954_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0022-2836(67)90307-5","volume":"26","author":"B Hirt","year":"1967","unstructured":"Hirt, B. Selective Extraction of Polyoma DNA from Infected Mouse Cell Cultures. J. Mol. Biol. 26, 365\u2013369 (1967).","journal-title":"J. Mol. Biol."},{"key":"20954_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jviromet.2004.08.012","volume":"122","author":"K Ziegler","year":"2004","unstructured":"Ziegler, K., Bui, T., Frisque, R. J., Grandinetti, A. & Nerurkar, V. R. A rapid in vitro polyomavirus DNA replication assay. J. Virol. Methods. 122, 123\u2013127 (2004).","journal-title":"J. Virol. Methods."},{"key":"20954_CR32","doi-asserted-by":"publisher","first-page":"e81489","DOI":"10.1371\/journal.pone.0081489","volume":"8","author":"XJ Zhang","year":"2013","unstructured":"Zhang, X. J. et al. DB-02, a C-6-cyclohexylmethyl substituted pyrimidinone HIV-1 reverse transcriptase inhibitor with nanomolar activity, displays an improved sensitivity against K103N or Y181C than S-DABOs. PLoS ONE 8, e81489 (2013).","journal-title":"PLoS ONE"},{"key":"20954_CR33","first-page":"241","volume":"45","author":"SY Liu","year":"2010","unstructured":"Liu, S. Y., Zhuang, D. M., Dong, R. H., Bai, L. & Li, J. Y. In vitro selection and identification of HIV strain which is resistance to two new HIV-1 nonnucleoside reverse transcriptase inhibitors. Acta Pharm. Sin. 45, 241\u2013246 (2010).","journal-title":"Acta Pharm. Sin."},{"key":"20954_CR34","doi-asserted-by":"publisher","first-page":"e105617","DOI":"10.1371\/journal.pone.0105617","volume":"9","author":"RR Wang","year":"2014","unstructured":"Wang, R. R. et al. Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro. PLoS ONE 9, e105617 (2014).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20954-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20954-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20954-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:06:01Z","timestamp":1671588361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20954-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,7]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["20954"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-20954-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,7]]},"assertion":[{"value":"6 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2574"}}